Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.
about
Pasireotide: a novel treatment for patients with acromegalyShort and tall stature: a new paradigm emergesStructural variation mutagenesis of the human genome: Impact on disease and evolution.MEN1, MEN4, and Carney Complex: Pathology and Molecular GeneticsSomatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjectsGermline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.X-linked acrogigantism syndrome: clinical profile and therapeutic responsesLandscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome.Pituitary adenoma with paraganglioma/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and micePituitary gigantism: update on molecular biology and managementGenomic insights into growth and its disorders: an update.Multiallelic Positions in the Human Genome: Challenges for Genetic Analyses.Pituitary Medicine From Discovery to Patient-Focused Outcomes.Somatic GPR101 Duplication Causing X-Linked Acrogigantism (XLAG)-Diagnosis and Management.cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors.Carney triad can be (rarely) associated with germline succinate dehydrogenase defects.GNB5 Mutations Cause an Autosomal-Recessive Multisystem Syndrome with Sinus Bradycardia and Cognitive Disability.Increased Population Risk of AIP-Related Acromegaly and Gigantism in Ireland.Childhood acromegaly due to X-linked acrogigantism: long term follow-up.The genetic background of acromegaly.Progress in the Diagnosis and Classification of Pituitary Adenomas.Decade in review-paediatric endocrinology: New genes, new therapies.Clinical identification of oncogenic drivers and copy number alterations in pituitary tumors.Emerging Histopathological and Genetic Parameters of Pituitary Adenomas: Clinical Impact and Recommendation for Future WHO Classification.Skin manifestations of growth hormone-induced diseases.Genetics of gigantism and acromegaly.Acromegaly: clinical features at diagnosis.Toward the next step in G protein-coupled receptor research: a knowledge-driven analysis for the next potential targets in drug discovery.Overview of the 2017 WHO Classification of Pituitary Tumors.Landscape of Genomic Alterations in Pituitary Adenomas.Surgical Management of Carney Complex-Associated Pituitary Pathology.Genome-wide association study identifies 112 new loci for body mass index in the Japanese population.Screening for GPR101 defects in pediatric pituitary corticotropinomasAdrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome.Characterization of GPR101 transcript structure and expression patterns.Regulation of Gonadotropin-Releasing Hormone-(1-5) Signaling Genes by Estradiol Is Age Dependent.AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience.Combined treatment with octreotide LAR and pegvisomant in patients with pituitary gigantism: clinical evaluation and genetic screening.The future: genetics advances in MEN1 therapeutic approaches and management strategies.
P2860
Q26774437-D52944CB-9D66-498B-AB03-80107AECD9A6Q26781983-F834F758-6826-4D1C-8B30-C3425FE23B31Q27691419-288FB951-2228-480F-9CCF-303078052C2BQ28088746-D4CD21C9-369C-45FD-9335-98EC117854C2Q28394993-3FF7415E-C140-4750-93BD-FF05D605B174Q30276702-5DB3FF05-2AFB-4F20-B11F-EBAF507E424DQ30370618-C42F62CD-D477-4B56-9602-58251CA2A410Q30370834-653565ED-CBEB-4480-BE3A-4AD7CAE0EA4DQ33872368-AC361BA5-0DBD-4EB2-9CA2-45FE88D1968CQ35578261-AEFD4831-C0D1-4F3C-9077-F64F0CABD2B3Q36503893-DED4B52F-EFBF-4E71-9C8D-E7CC46F1E074Q36523621-329650AA-E69A-4683-84ED-D3D374C04380Q36576540-F3525EFF-C533-4D51-8A0A-ADB34F9C67BDQ36716025-F37CDE5C-BEAB-4031-8E04-60D1578ADA97Q36911483-11F30744-50D3-48B4-A05F-DB8777AD66FEQ36991419-3004C87E-4545-48C0-9C46-0E75644D2696Q37058010-14278F5E-08CB-4987-824F-DEC017EA2F93Q37230697-B42126F8-2115-4B08-8B3B-9EF867733990Q37561016-C0F29FCE-A2E3-4044-B5EC-97287F2A6D3AQ37593900-542A4847-F649-445E-8FF8-55E538318F06Q37678059-18898DAD-3267-447A-AE0A-A52EADEBB52CQ38540507-51AFC221-7023-45AD-B264-037B08D05ED5Q38582557-5FA8FF87-D4D5-46E7-A90F-29AB25F53A05Q38685960-E4697805-BC8B-46F3-BD9A-F7FBAB265DD5Q38732499-C7ED45CE-B94A-46C3-94B9-17B8DA09EA38Q38939860-DEE9B8D6-EF5D-4783-BCC5-2EFDA1C8E3C3Q38961684-6AB5A20D-4EB4-4736-B61C-D2AEAF4FA417Q38998304-D6255642-5F9C-4784-9A1D-6473ED8591D8Q39034639-B4DA2305-34DC-47E4-8FC3-2EB0AF0D8E28Q39190559-6883BE64-3106-4B46-B8CD-92EF927FE934Q39319278-CD6EFF63-44A5-4920-9BC2-D1290D17F997Q39504353-FCF7764E-371B-41D4-BA70-D03F02A2B21FQ40047877-20581B90-437B-49D9-A08A-CABCBDE75404Q41057633-57C8E457-0064-4CE2-9A00-889DE81B4F6DQ42105577-8BDDBE3F-296F-4156-9A5A-15EDDF49FFA9Q42406647-B86871A1-EBCA-4BE7-A09B-11765BDEE5D3Q47146813-BFB7B240-B31D-479F-AED1-7CC259350DD1Q47322124-3475A945-7073-4C6C-B065-C0AC75611111Q47773067-05952363-E76D-4D9D-A8B7-16678A42480AQ47814736-ACE73FFD-EDB8-401F-A48D-65E96D4671B9
P2860
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation
@nl
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.
@ast
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.
@en
type
label
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation
@nl
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.
@ast
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.
@en
prefLabel
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation
@nl
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.
@ast
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.
@en
P2093
P2860
P50
P3181
P356
P1476
Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.
@en
P2093
Aggeliki Dimopoulos
Albert Beckers
Allison D Manning
Anelia Horvath
Catherine S Choong
Chiara Villa
Darwin O Larco
Emilie Castermans
Eva Szarek
P2860
P304
P3181
P356
10.1056/NEJMOA1408028
P407
P50
P577
2014-12-03T00:00:00Z